Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Antimicrob Agents Chemother ; 36(8): 1688-94, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1384425

ABSTRACT

(-)-2'-Deoxy-3'-thiacytidine (3TC) is a selective inhibitor of human immunodeficiency virus replication in vitro (J. A. V. Coates, N. Cammack, H. J. Jenkinson, A. J. Jowett, M. I. Jowett, B. A. Pearson, C. R. Penn, P. L. Rouse, K. C. Viner, and J. M. Cameron, Antimicrob. Agents Chemother. 36:733-739, 1992). The effect of 3TC 5'-triphosphate on both the RNA-dependent and DNA-dependent activities of human immunodeficiency virus type 1 reverse transcriptase and DNA polymerases alpha, beta, and gamma from HeLa cells was investigated. 3TC 5'-triphosphate is a competitive inhibitor (with respect to dCTP) of the RNA-dependent DNA polymerase activity (apparent Ki = 10.6 +/- 1.0 to 1.24 +/- 5.1 microM, depending on the template and primer used); the DNA-dependent DNA polymerase activity is 50% inhibited by a 3TC 5'-triphosphate concentration of 23.4 +/- 2.5 microM when dCTP is present at a concentration equal to its Km value. Chain elongation studies show that 3TC 5'-triphosphate is incorporated into newly synthesized DNA and that transcription is terminated in a manner identical to that found for ddCTP. The 50% inhibitory concentrations of 3TC 5'-triphosphate against DNA polymerases alpha, beta, and gamma at concentrations of dCTP equal to the Km were 175 +/- 31, 24.8 +/- 10.9, and 43.8 +/- 16.4 microM, respectively. More detailed kinetic studies with 3TC 5'-triphosphate and DNA polymerases beta and gamma are consistent with the fact that inhibition of these enzymes by 3TC 5'-triphosphate is competitive with respect to dCTP. The values of Ki were determined to be 18.7 microM for DNA polymerase beta and 15.8 +/- 0.8 microM for DNA polymerase gamma.


Subject(s)
Antiviral Agents/pharmacology , HIV/enzymology , Nucleic Acid Synthesis Inhibitors , Reverse Transcriptase Inhibitors , Zalcitabine/analogs & derivatives , Base Sequence , DNA Polymerase I/antagonists & inhibitors , DNA Polymerase I/isolation & purification , DNA Polymerase II/antagonists & inhibitors , DNA Polymerase II/isolation & purification , DNA Polymerase III/antagonists & inhibitors , DNA Polymerase III/isolation & purification , DNA-Directed DNA Polymerase/isolation & purification , DNA-Directed DNA Polymerase/metabolism , Kinetics , Lamivudine , Molecular Sequence Data , Nucleotides/analysis , Nucleotides/metabolism , Peptide Chain Termination, Translational , Polyribonucleotides/metabolism , RNA-Directed DNA Polymerase/isolation & purification , Zalcitabine/pharmacology
2.
J Biol Chem ; 267(6): 4177-82, 1992 Feb 25.
Article in English | MEDLINE | ID: mdl-1371285

ABSTRACT

Carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine (carbovir, NSC 614846) is an anti-retroviral agent that may be useful in the treatment of AIDS. We have examined the ability of (-)-enantiomeric carbovir triphosphate to inhibit human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (EC 2.7.7.49). A comparison of inhibition kinetics was made with 3'-azido-2',3'-dideoxythymidine triphosphate and phosphonoformate. Inhibition of the reverse transcriptase was evaluated using poly(rA).oligo(dT)12-18, poly(rC).oligo(dG)12-18, or influenza virion RNA template with a specific oligodeoxynucleotide as primer. (-)-Carbovir 5'-triphosphate was shown to be a potent inhibitor of HIV-1 reverse transcriptase with an apparent Ki similar to that of 3'-azido-2',3'-dideoxythymidine triphosphate. Chain elongation studies utilizing an MS2 RNA template showed that (-)-carbovir 5'-triphosphate terminated transcription at positions identical to those where dideoxy-GTP terminated. This indicates that (-)-carbovir 5'-monophosphate is incorporated into the newly synthesized DNA and terminates transcription at that point. We conclude that (-)-carbovir 5'-triphosphate is a potent inhibitor of the HIV-1 reverse transcriptase enzyme and that (-)-carbovir most likely inhibits HIV by activity at the triphosphate level by a combination of direct competition for binding of the natural deoxynucleoside triphosphates to the reverse transcriptase and chain termination.


Subject(s)
Antiviral Agents/pharmacology , DNA, Viral/drug effects , Dideoxynucleosides/pharmacology , HIV-1/drug effects , Reverse Transcriptase Inhibitors , Transcription, Genetic/drug effects , Base Sequence , DNA, Viral/genetics , Escherichia coli/metabolism , HIV Reverse Transcriptase , HIV-1/enzymology , Kinetics , Molecular Sequence Data , RNA-Directed DNA Polymerase/metabolism , Zidovudine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...